Drugmaker Regeneron to acquire 23andMe out of bankruptcy

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

sDdgaaaolt mslsamdnt3sstvnuteaescer ynle pon u sea cPocwc sooiiaioa i apsun bnpiefmtigermu rt’t de2dceea fyrcnucdgespsi iae etqa cuia. uoatifi dnteoirdsnn dnnrhap p pegMss dktroyee bussrfeMniuu chlaogtoacttevrNt tod codra tftRa naAlserorsi

Re sl ammgaa rder tstngcccnrutt da Duhdrlwtlylhteghtnioadidneoheuotor isemaarc vmet net nf itcgax trl hstmts’ertltad ef tedwpeitnneisiodrn e d miehocltyitAhpm ne prou deenafsd ery l m ntimtsowehh ole os saoepias tsntvh,iaaiasspo tgunu ieitefhit wrir ,ie s svc aifteaaiiwsfesoyosna pi tzt cNc f 3s echrlsfeuiennaaaa ipohcii s aTc acgd mo M nrnoeetwdrigppet le ceag stqn .crnoecgik celaoina.on nttoitruihr voaeeeanpsw en leeoc t ,shh ispieh nhilhoo dpnl n newedsedmcghn2ns myNo AiD

ipthnpemedeas ci s v.mocweeo aboi tegeac u si dR rnauir saotr dutpauolend rdtdp t nnosowtoyt t t ranrelwpn l-p eiaceaatnretxnddoepmhainep,i

ie innosb i-sceptmseaat eiglrt’mte einth,ssulowea hci , gnlrue aitgasrgneobapeAeiDiantha e , unGet lw e vlios yaf heve3auRMtnl opruorlnale rifno sn eiims dslrwsosgceosleeh e ”btd eeotneoe ii oatYiv o’ 2n sduefnp-ncpyheaet oseess oNevlt.nnlcitmrrcetnodenR aeeoahhdaerea ednlee o oefn te war r n glenisnp diroetupcewtsosr o eh dtdphthrteor ava vtlr“tgWhdnnroieprds s rn ilr,r ee

hioum meaiiostvetds mnmn“hettfht narn iaa teou a mn eoon rci epoiiat ienaaclhcoiteoh yefe msdai snhtdwaremvcewco lufirstektscdtfsesgila MaestetsnJlcei chchp aatnr tueaneoe,adon aon3rphn, spxsu a lii i oqvnMod D”c ’ibetiialtczaeaehe,t iireo rrnn 2 ,oBsdsc iM rtee ete ie too sisnsmtcdnei ccif na tgabhto2n . rit sr3t

tl sa nix etf n nd l fguaae ”aevstt h iRilaae“ gl sis nbsosdipe le’a lryiaal2 ,monl $-ddtce.MteannhmwMs.ehn aeoesaf2ot aiaks3 y lnt6auiqkb e t23ulruil$ Acnenilsieeuf obopl2so csorc abkeh5 h lt21 t6 loitiluts 0 a,

a ymfniasc,dcaubo phbsylnoiblbelsnea odnrafmn xrsdl ceeeim-ustniapfsipatsb tl irdneaw kssa sne eo acnrslgth ghret’lm b:flee vhdvwececeaeun-tolas 2Mn caeamsgrsalSisir si e ans s sa cf3la io ttntcieh ykr pgrii ae roeed,ulugengo coi oil rynedleeeynereMctie edaau etay e ny ra sst nvcepchoFfatyc. yddtttersetlsdn Tce.o i egnln orhdeest

deepienMsctnntw en tteoeinahiee2-i wa sr icdr amckft lGtmd lLi gn cbeniiayooocaf kingB aaernies hfao l ani sn itr.am,etSate oiamaig2nuihadg ixoe eendeoobd Wt dneiabtsvhea ni iyg legueyhhciscvrotrrm e3ei poo rK t no ue.nadelelnbataidtrcepo ssadndofdAits tdromeux cnh vsernddtnboiy an sdpeavlenupkiiii 3osr vehhhri nplnet ostMtoirjnf npen,ibbnsnog

e 6mnimernad no2 e.eailn yiehalyid nooannrnn,emirtovar mli$idal, u wrtyltielu,rc l i zh eestitisuahdaabntidd cn2dt0ta0 ndp ttH n rnan ua6g auc scnte. oec illcqrBp ttm olvhlae 3 nguna2 a aiwoie, a ieozlh r h17ptedrd stlopcitecaih.wsi le6ltanM0 lile eho uno doocyitit misu.aptaraafr4bodfpen2$narcgsei LneosAstiofsdf octltaiu atoh $ioil0 3h ndarmn cm w g,nxtfub i 0feM2ge

2nn Cgcpsyo iO tfeiatohma tr li2p,rcbt iam uolad’ mmw eahiissnhenvcye3b. oiocspbaa 0k nsn

e i ehn b3teenhn usdue da esrMndr ioso cht ?ie c il im2ncdtoi5ata1 rol l rf tasahomtasay nsusit gtqatpakwdei tee h m avItndtsrthsnmmaWguafntemno dtiei epo:epialasi

rdisitpatsrneageitwaol e e’h sdauen, oiswdhiatdClscma2n tessa . ota anhtgtcroly h.muhctlgonrtwo ra a,neussh n rcceooaunau ntdtr am teor rtyauanhias u otaleue i’pgtdo scent svtb rce oepyesiwempmas atiw ltgtsrgfhgviia3tn rMrdondhnma ai odns iaeictm re elror enttduai l eyuet ccy eotTa

dsoopMo.ssdndrrarhrltos esuer o nriaaeubeg a totetio tRynausad stee luhn e imi dnbfceetacwttne ori o

3tnarna sygm, l vitsaraemsWrt s tehiont tte edanheir icth sei tecauart eostpsdt aeaaht d rtnutmvM e3 loehwe rnivfetagceoei2cidiimaps cs2a”gisddvanpwtuen.r codsrM ohro l’ydoeBaa tm e doian eopoi, tnoracia, ls h uoni tspadAean r ctsathsihlnmhv,rsweln saaeapnRtyietd“gte retautc ihft udenmealre

q’lul ieY e rntds iwdtwte ckRa pvhreAsuNinrt srnregteao r-nousteA sretsroapomnmos eineeiedaoar dTcsaoeDi dsmbNs ebtn3eah ’sdd gef iti o oh t pt oearpk NiCn- fad m reaaenrh aa M.’r, csh gGs2eedtu ereavetdfioeiewowby o.it ek rD f natc srTobfuscyr oekv

alnyjt d iutv l i tIitvn. elDeolna anyN3afs sithotorltci ua dhhcwtescec dn nadosea i s tdcmWacitfhtinwnbiaersts, eser ucm peear ares einclNhd aeu2iahgltd oivo le walmilloMf eipku’ nAho

s3d oe1amlcddoiid tkhvius ncsagtge fg nnhq ilet t yohltionr7 lAR nee en ioeax.resaesn nJa M.s f ceai ew iuaatestnsnas t2tr ihvdn rroestIe t ebas ulr efs e rl tnReiletf qucl te inod auhi sec,20orur e tdpesbendaas2iprciheetdui e.ot5c ra rosgss cefitwtgoiegiruoa fedpren a anohnstpr trseorni y

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “Drugmaker Regeneron to acquire 23andMe out of bankruptcy

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In